Dark-adapted b-wave luminance function: comparison of two mathematical models in normal subjects and in patients with retinal dystrophy (2010)
- Autores:
- Autores USP: JORGE, RODRIGO - FMRP ; MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP
- Unidade: FMRP
- Assuntos: DOENÇAS RETINIANAS; ELETROFISIOLOGIA
- Idioma: Inglês
- Imprenta:
- Local: Fort Lauderdale
- Data de publicação: 2010
- Fonte:
- Título do periódico: Abstracts
- Nome do evento: Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
-
ABNT
MESSIAS, André Márcio Vieira et al. Dark-adapted b-wave luminance function: comparison of two mathematical models in normal subjects and in patients with retinal dystrophy. 2010, Anais.. Fort Lauderdale: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2010. . Acesso em: 18 abr. 2024. -
APA
Messias, A. M. V., Jaegle, H., Gekeler, F., Jorge, R., Siqueira, R. C., & Zrenner, E. (2010). Dark-adapted b-wave luminance function: comparison of two mathematical models in normal subjects and in patients with retinal dystrophy. In Abstracts. Fort Lauderdale: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Messias AMV, Jaegle H, Gekeler F, Jorge R, Siqueira RC, Zrenner E. Dark-adapted b-wave luminance function: comparison of two mathematical models in normal subjects and in patients with retinal dystrophy. Abstracts. 2010 ;[citado 2024 abr. 18 ] -
Vancouver
Messias AMV, Jaegle H, Gekeler F, Jorge R, Siqueira RC, Zrenner E. Dark-adapted b-wave luminance function: comparison of two mathematical models in normal subjects and in patients with retinal dystrophy. Abstracts. 2010 ;[citado 2024 abr. 18 ] - Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema
- Intravitreal autologous bone marrow derived stem cells in ischemic macular edema: results after 6 months follow-up
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
